Evidence map›Paper›PMID 42293388›Full record

ReviewMaterials today. Bio2026

The mechano-immunological landscape in the tumor microenvironment: From mechanical sensing to a new therapeutic paradigm.

Wen Li, Yuan-Yuan Xin, Ming-Zhu Jin, Wei-Lin Jin

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wen LiInstitute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, PR China.
Yuan-Yuan XinInstitute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, PR China.
Ming-Zhu JinDepartment of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, PR China.
Wei-Lin JinInstitute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment (TME) is a complex ecosystem where mechanical forces are now recognized not as passive byproducts but as active drivers critically shaping anti-tumor immunity. This review introduces the integrative concept of the "Mechano-immunological Landscape" (MIL) to delineate the dynamic and spatially heterogeneous network of interactions between mechanical cues and immune cells within tumors. We systematically elaborate on its three core pillars: Mechano-immunological Checkpoints, Mechano-immune Memory, and Landscape Plasticity. Building upon this framework, we propose a novel therapeutic paradigm termed "Mechano-immunological Landscape Remodeling Therapy" (MILRT). This paradigm discusses potential strategies to reverse immune suppression and enhance anti-tumor efficacy by modulating the mechanical TME, including matrix de-stiffening, mechanical empowerment of immune cells, and targeting mechano-immunological checkpoints. Finally, we outline future research trajectories, pivotal challenges, and clinical translation prospects in this burgeoning field. We position MILRT as a multi-pronged and synergistic framework that leverages advanced biomaterials and biophysical tools to overcome current limitations in drug delivery and immunotherapy resistance, thereby paving the way for next-generation, mechano-aware immunotherapies and redefining the future of solid tumor treatment.

Indexed as

Immune checkpointMechano-immunological landscapeMechano-immunotherapyMechanotransductionPIEZO1Therapeutic paradigm

Identifiers

PMID42293388
PMCPMC13264376

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.